Allspring Diversified Income Builder Fund Q4 2025 Commentary

The Allspring Diversified Income Builder Fund outperformed its benchmark in Q4 2025 amid global equity gains. Read the full ...
KFGO

Gilead boosts immunology pipeline with over $2 billion buyout of Ouro Medicines

Gilead Sciences said on Monday it would buy privately held biotech firm Ouro Medicines in a deal worth more than $2 billion ...

Zimmer Biomet: Down On Its Knees, Shares Look Appealing

Shares of Zimmer Biomet (ZBH) cannot seem to catch a break, even as the company sees steady growth here. Shares have ...
The Manila Times

Arbutus Reports Fourth Quarter and Year End 2025 Financial Results and Provides Corporate Update

As part of the settlement, Moderna will pay Arbutus and Genevant $950 million upfront in July 2026 ("Noncontingent Settlement ...
Zacks Small Cap Research on MSN

CPKF: Raising our CPKF 2026 diluted EPS estimate by $0.58 to $3.90

By Ann Heffron, CFA, CPA OTCQX: CPKF READ THE FULL CPKF RESEARCH REPORT Chesapeake Financial Shares, Inc. (OTCQX: CPKF) produced another outstanding quarter with 2025 fourth quarter net earnings ...